Myriad Genetics CEO Mark Capone's 2019 pay jumps 26% to $8.9M
Myriad Genetics reports 2019 executive compensation
By ExecPay News
Published: October 16, 2019
Myriad Genetics reported fiscal year 2019 executive compensation information on October 16, 2019.
In 2019, five executives at Myriad Genetics received on average a compensation package of $4.1M, a 20% increase compared to previous year.
Average pay of disclosed executives at Myriad Genetics
Mark C. Capone, Chief Executive Officer, received $8.9M in total, which increased by 26% compared to 2018. 81% of Capone's compensation, or $7.2M, was in stock awards. Capone also received $200 in bonus, $803K in non-equity incentive plan, $887K in salary, as well as $29K in other compensation.
For fiscal year 2019, the median employee pay was $77,814 at Myriad Genetics. Therefore, the ratio of Mark C. Capone's pay to the median employee pay was 114 to one.
Alexander Ford, President, Myriad Genetic Laboratories, received a compensation package of $3.2M, which increased by 17% compared to previous year. 74% of the compensation package, or $2.4M, was in stock awards.
R. Bryan Riggsbee, Chief Financial Officer, earned $3.1M in 2019, a 19% increase compared to previous year.
Jerry S. Lanchbury, Chief Scientific Officer, received $2.7M in 2019, which increases by 13% compared to 2018.
Richard M. Marsh, General Counsel, earned $2.7M in 2019, a 13% increase compared to previous year.
Myriad Genetics' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on October 16, 2019.